Zhou et al. further showed an in-depth screening of SCN1A ASOs, their effect in upregulating mRNA and protein expression in mice, and their striking effects in rescuing lethality in a Dravet syndrome mouse model (Han et al., 2020). Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.